Skip to main content
James Howard, MD, Neurology, Chapel Hill, NC, University of North Carolina Hospitals

JamesHowardMDFAAN

Neurology Chapel Hill, NC

Neuromuscular Medicine, Neurophysiology

Professor, Neurology, Medicine & Allied Health, University of North Carolina-Chapel Hill School of Medicine

Dr. Howard is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Howard's full profile

Already have an account?

Summary

  • Dr. James Howard is a neurologist in Chapel Hill, NC and is affiliated with University of North Carolina Hospitals. He received his medical degree from The Robert Larner, M.D. College of Medicine at The University of Vermont and has been in practice 43 years. He specializes in neuromuscular medicine and neurophysiology and is experienced in general neurology, electromyography, clinical research, neuromuscular medicine, and clinical neurophysiology.

Education & Training

  • University of Virginia Medical Center
    University of Virginia Medical CenterFellowship, Neuromuscular Medicine (Neurology), 1978 - 1979
  • University of Virginia Medical Center
    University of Virginia Medical CenterResidency, Neurology, 1975 - 1979
  • Albany Medical Center
    Albany Medical CenterInternship, Internal Medicine, 1974 - 1975
  • University of Vermont College of Medicine
    University of Vermont College of MedicineClass of 1974

Certifications & Licensure

  • NC State Medical License
    NC State Medical License 1979 - 2025
  • VA State Medical License
    VA State Medical License 1978 - 2020
  • American Board of Psychiatry and Neurology Neurology
  • American Board of Electrodiagnostic MedicineEMG

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Newsworthy from the School of Medicine, Week of December 27 – December 30
    Newsworthy from the School of Medicine, Week of December 27 – December 30December 30th, 2021
  • Ra Pharmaceuticals Announces Dosing of First Patient in Global Phase 3 Pivotal Study of Zilucoplan for gMG
    Ra Pharmaceuticals Announces Dosing of First Patient in Global Phase 3 Pivotal Study of Zilucoplan for gMGOctober 2nd, 2019
  • Ra Pharmaceuticals Delivers on Midstage Muscle Study
    Ra Pharmaceuticals Delivers on Midstage Muscle StudyDecember 10th, 2018
  • Join now to see all

Professional Memberships

Hospital Affiliations